News for Covalon Technologies Ltd. (COV.V)

Revenue: $8 million, representing a 75% year-on-year growth.Adjusted EBITDA: $1.5 million, a $2.9 million improvement over the previous year.Trailing 12 Months

Feb 21, 2025 / 01:30PM GMTOperator Good morning, ladies and gentlemen, and welcome to Covalon Technologies Ltd Q1 Cisco 2025 conference call and webcast. My nam

Covalon Technologies Ltd. (OTCQX:CVALF) Q1 2025 Earnings Conference Call February 21, 2025 8:30 AM ETCompany ParticipantsBrent Ashton - Chief Executive...

MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced …

MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to an…

**media[515644]**

Covalon Technologies Ltd. (OTCQX:CVALF) Q4 2024 Earnings Conference Call January 7, 2025 8:30 AM ETCompany ParticipantsBrent Ashton - CEOSaleha Assadzada -...

The following slide deck was published by Covalon Technologies Ltd.

Biocompatible Coatings Industry size is expected to register 9.4% CAGR between 2024 and 2032 propelled by increasing demand in healthcare industry....

The biocompatible coating market is driven by increased demand in medical implants and devices for reduced rejection rates, alongside advancements in...

Visit Covalon at booth 523 to discover the latest in compassionate vascular access solutions Visit Covalon at booth 523 to discover the latest in compassionate vas…

Medical Device Coating Market demand is growing due to the emphasis on environmentally friendly and sustainable coatings, aligning with broader industry...

Earnings call: Covalon reports a revenue growth of 47% compared to the same period last year

Revenue: $9.2 million, a 47.1% increase from $6.3 million in the prior year period.Product Revenue: $9.2 million, a 52.6% increase from $6 million in the prior

Aug 21, 2024 / 12:30PM GMTOperator Good morning, ladies and gentlemen, and welcome to Covalon's Q3 fiscal 2024 conference call and Webcast. My name is Laura, an

Wound Healing Films Gaining Prominence Due to Their Enhanced Breathability and Improved Adherence Features...

Activist Group under scrutiny after NorthWest files application with British Columbia Securities Commission to protect minority shareholders from potential...

BLUE proxies must be received by the proxy voting deadline of 10:00 a.m. on September 15th, 2023 in order to be counted at the Annual MeetingShareholders should contact NorthWest’s strategic...

/PRNewswire/ -- The